[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

September 2019 - April 2016

Decade

Year

Issue

July 2018, Vol 3, No. 7, Pages 549-665

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2018;3(7):549. doi:10.1001/jamacardio.2017.3371
Original Investigation

Outcomes of Care for Ischemic Heart Disease and Chronic Heart Failure in the Veterans Health Administration

Abstract Full Text
free access
JAMA Cardiol. 2018;3(7):563-571. doi:10.1001/jamacardio.2018.1115

This cohort study investigates whether there are substantial differences in mortality rates for patients with ischemic heart disease and chronic heart failure who received care at Department of Veterans Affairs medical centers.

Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults: An Analysis of National Data

Abstract Full Text
free access has audio
JAMA Cardiol. 2018;3(7):572-581. doi:10.1001/jamacardio.2018.1240

This study estimates the potential association of the 2017 and 2014 hypertension guideline treatment goals with the proportion of US adults defined as being hypertensive or recommended for antihypertensive treatment.

Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population

Abstract Full Text
free access
JAMA Cardiol. 2018;3(7):583-590. doi:10.1001/jamacardio.2018.1233

This cohort study uses participant data from the Japan Morning Surge–Home Blood Pressure study to examine the association between hypertension defined by a home blood pressure device and the risk for stroke and other adverse cardiovascular outcomes.

Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction

Abstract Full Text
free access
JAMA Cardiol. 2018;3(7):591-600. doi:10.1001/jamacardio.2018.1049

This cohort study provides contemporary estimates of sudden and/or arrhythmic death vs other competing causes of death in patients with coronary heart disease without severe systolic dysfunction to search for high-risk subgroups that might be targeted in future trials of prevention of sudden and/or arrhythmic death.

Association of Burden of Atrial Fibrillation With Risk of Ischemic Stroke in Adults With Paroxysmal Atrial Fibrillation: The KP-RHYTHM Study

Abstract Full Text
open access
JAMA Cardiol. 2018;3(7):601-608. doi:10.1001/jamacardio.2018.1176

This cohort study analyzes the association between the burden of atrial fibrillation on 14-day noninvasive, continuous electrocardiographic monitoring and the rate of thromboembolism among adults with paroxysmal atrial fibrillation while not taking anticoagulation.

Association of Medical Liability Reform With Clinician Approach to Coronary Artery Disease Management

Abstract Full Text
free access
JAMA Cardiol. 2018;3(7):609-618. doi:10.1001/jamacardio.2018.1360

This difference-in-differences study examines whether reducing malpractice risk is associated with clinical decisions involving coronary artery disease testing and treatment.

Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis

Abstract Full Text
open access
JAMA Cardiol. 2018;3(7):619-627. doi:10.1001/jamacardio.2018.1470

This mendelian randomization analysis estimates the magnitude of the change in plasma lipoprotein(a) levels needed to have the same evidence of an association with coronary heart disease risk as a 38.67-mg/dL change in low-density lipoprotein cholesterol level.

Brief Report

A Survey of Interventional Cardiologists’ Attitudes and Beliefs About Public Reporting of Percutaneous Coronary Intervention

Abstract Full Text
free access
JAMA Cardiol. 2018;3(7):629-634. doi:10.1001/jamacardio.2018.1095

This survey assesses how public reporting of percutaneous coronary intervention outcomes influences clinical decision making among interventional cardiologists in Massachusetts and New York.

Viewpoint

Frequency of Plaque Dislodgement and Embolization in Transradial vs Transfemoral Approaches for Left-Sided Cardiac Catheterization: Clinically Silent vs Clinically Apparent Embolism

Abstract Full Text
JAMA Cardiol. 2018;3(7):551-552. doi:10.1001/jamacardio.2018.0981

This Viewpoint discusses the frequency of plaque dislodgement and embolization in 2 contrasting approaches to left-sided cardiac catherization.

From the Heart

Without Words

Abstract Full Text
JAMA Cardiol. 2018;3(7):561-562. doi:10.1001/jamacardio.2018.0232

This From the Heart describes a patient with fibrosis who remained her primary advocate through her end of life.

Editorial

In Pursuit of Better Measures of Quality of Care

Abstract Full Text
JAMA Cardiol. 2018;3(7):553-554. doi:10.1001/jamacardio.2018.1204

Blood Pressure Control—Much Has Been Achieved, Much Remains to Be Done

Abstract Full Text
has audio
JAMA Cardiol. 2018;3(7):555-556. doi:10.1001/jamacardio.2018.1259

Sudden Cardiac Deaths—WHO Says They Are Always Arrhythmic?

Abstract Full Text
JAMA Cardiol. 2018;3(7):556-558. doi:10.1001/jamacardio.2018.1008

When Low-Risk Atrial Fibrillation Is Not So Low Risk: Beast of Burden

Abstract Full Text
JAMA Cardiol. 2018;3(7):558-560. doi:10.1001/jamacardio.2018.1205
Invited Commentary

Optimizing Transparency to Empower Patients

Abstract Full Text
JAMA Cardiol. 2018;3(7):640-641. doi:10.1001/jamacardio.2018.0955
Special Communication

Public Reporting of Percutaneous Coronary Intervention Outcomes: Moving Beyond the Status Quo

Abstract Full Text
JAMA Cardiol. 2018;3(7):635-640. doi:10.1001/jamacardio.2018.0947

This special communication examines the challenges, opportunities, and alternatives surrounding public reporting programs for percutaneous coronary intervention outcomes in the United States.

Review

Left Ventricular Thrombus After Acute Myocardial Infarction: Screening, Prevention, and Treatment

Abstract Full Text
JAMA Cardiol. 2018;3(7):642-649. doi:10.1001/jamacardio.2018.1086

This narrative review provides an overview of the epidemiology, pathogenesis, diagnosis, prevention, and treatment of left ventricular thrombus after acute myocardial infarction and offers guidance regarding a practical antithrombotic approach in this setting.

Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure: A Review

Abstract Full Text
has active quiz has audio
JAMA Cardiol. 2018;3(7):650-658. doi:10.1001/jamacardio.2018.0522

This review summarizes the history, considerations for use, and future direction of left ventricular assist device therapy for advanced heart failure.

JAMA Cardiology Clinical Challenge

Malignant Arrhythmia in a 40-Year-Old Man

Abstract Full Text
has active quiz has multimedia
JAMA Cardiol. 2018;3(7):661-662. doi:10.1001/jamacardio.2017.4508

A 40-year-old man who smoked with a self-described heart valve problem and several days of flulike symptoms presented to the emergency department with acute onset of palpitations and diaphoresis. What would you do next?

JAMA Cardiology Clinical Guidelines Synopsis

The 2017 AHA/ACC Performance and Quality Measures for Patients With Acute Myocardial Infarction

Abstract Full Text
JAMA Cardiol. 2018;3(7):659-660. doi:10.1001/jamacardio.2018.0263

This synopsis of the 2017 Amercian Heart Association/American College of Cardiology Clinical Performance and Quality Measures for Adults with ST-Elevation and Non–ST-Elevation Myocardial Infarction discusses new guidelines for treatment of patients with ST-elevation and non–ST-elevation myocardial infarction.

Comment & Response

Premature Cardiac Disease and Death After Preterm Preeclampsia in Women Whose Infant Was Small for Gestational Age

Abstract Full Text
JAMA Cardiol. 2018;3(7):664. doi:10.1001/jamacardio.2018.1209

Premature Cardiac Disease and Death After Preterm Preeclampsia in Women Whose Infant Was Small for Gestational Age

Abstract Full Text
JAMA Cardiol. 2018;3(7):664-665. doi:10.1001/jamacardio.2018.1212

Premature Cardiac Disease and Death After Preterm Preeclampsia in Women Whose Infant Was Small for Gestational Age—Reply

Abstract Full Text
JAMA Cardiol. 2018;3(7):665. doi:10.1001/jamacardio.2018.1215
Editor's Note

The New Hypertension Guidelines: Compelling Population Benefit, Manageable Risk, and Time to Implement

Abstract Full Text
has audio
JAMA Cardiol. 2018;3(7):581-582. doi:10.1001/jamacardio.2018.1264

Mendelian Randomization Evidence for Cardiovascular Precision Medicine

Abstract Full Text
JAMA Cardiol. 2018;3(7):627-628. doi:10.1001/jamacardio.2018.1543
Correction

Error in Axis Label in Figures

Abstract Full Text
free access
JAMA Cardiol. 2018;3(7):665. doi:10.1001/jamacardio.2018.1559
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2018;3(7):550. doi:10.1001/jamacardio.2017.3372
×